| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||||||
Net Income (Loss) Attributable to Parent | ||||||||||||
-33,170 | -150,363 | 1,650 | 49,470 | -30,832 | -1,826 | -10,158 | -19,922 | -44,904 | -15,714 | 3,453 | -12,345 | -10,646 |
Adjustments to reconcile net loss to cash flows provided by operating activities: | ||||||||||||
Depreciation and amortization of property and equipment | ||||||||||||
3,474 | 3,125 | 2,933 | 2,970 | 2,921 | 2,930 | 2,952 | 2,811 | 2,507 | 3,231 | 1,660 | 1,772 | 1,823 |
Amortization of Intangible Assets | ||||||||||||
14,334 | 12,396 | 12,260 | 12,647 | 11,922 | 12,002 | 13,448 | 11,964 | 12,309 | 10,267 | 2,293 | 2,293 | 2,259 |
Amortization of debt issuance costs | ||||||||||||
1,854 | - | - | - | 88 | - | - | - | - | - | - | - | - |
Stock-based compensation | ||||||||||||
2,976 | 4,447 | 2,485 | 1,530 | 4,139 | 3,651 | 2,516 | 2,081 | 2,824 | 14,270 | 3,887 | 4,237 | 3,263 |
Deferred income taxes | ||||||||||||
99 | -740 | -201 | -4,011 | -347 | -552 | 856 | -289 | -528 | 21,048 | -241 | -208 | -238 |
Reduction in deferred purchase consideration | ||||||||||||
69 | 0 | 0 | 0 | 8,124 | 0 | 0 | 0 | 0 | - | - | - | - |
Foreign currency exchange losses | ||||||||||||
-854 | -48 | -521 | -169 | -352 | -1,545 | -987 | -2,056 | -23 | - | - | - | - |
Changes in operating assets and liabilities: | ||||||||||||
Accounts receivable | ||||||||||||
-46,156 | 29,534 | 7,523 | 20,733 | -53,854 | 37,567 | 4,202 | 10,988 | -39,740 | 33,119 | 8,957 | 3,007 | -14,324 |
Inventory | ||||||||||||
-4,468 | 611 | -2,228 | -2,467 | -3,692 | 1,790 | -706 | -2,489 | 412 | -3,980 | -977 | -514 | -315 |
Other operating assets | ||||||||||||
478 | -2,753 | -609 | 20,089 | 762 | -2,240 | -3,071 | -1,907 | 2,182 | -829 | -434 | 589 | 405 |
Accounts payable | ||||||||||||
-27,029 | 3,978 | -7,497 | -5,764 | -6,999 | 1,622 | 6,193 | -4,896 | -8,976 | 13,031 | 919 | 116 | -651 |
Accrued expenses and other long-term liabilities | ||||||||||||
22,310 | 2,997 | -4,406 | -4,034 | -13,095 | 6,611 | -4,830 | -2,383 | -12,820 | -1,235 | 5,061 | 2,441 | -10,530 |
Deferred revenue | ||||||||||||
4,351 | 18,778 | -9,949 | -13,016 | 2,076 | 23,976 | -10,677 | -11,491 | 14,755 | 19,859 | -3,848 | 4,234 | 3,614 |
Net cash provided by operating activities | ||||||||||||
39,932 | 33,054 | -6,488 | 9,540 | 19,579 | 13,946 | -850 | -26,083 | 3,392 | -967 | 6,206 | -763 | 3,604 |
Cash flows from investing activities: | ||||||||||||
Purchases of property and equipment | ||||||||||||
6,017 | 2,230 | 2,441 | 2,387 | 3,766 | 1,957 | 2,458 | 1,665 | 1,827 | 734 | 672 | 1,595 | 998 |
Payments to Acquire Businesses, Net of Cash Acquired | ||||||||||||
346,852 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Purchases of marketable securities | ||||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | 10,099 | 18,632 |
Maturities of marketable securities | ||||||||||||
0 | 0 | 0 | 2,000 | 5,295 | 0 | 14,641 | 4,033 | 245 | 54,148 | 12,897 | 13,374 | 15,693 |
Proceeds from the sale of fixed assets | ||||||||||||
43,500 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Net cash (used in) provided by investing activities | ||||||||||||
-309,369 | -2,230 | -2,441 | -387 | 1,529 | -1,957 | -34,206 | 2,368 | -1,582 | 10,463 | 12,225 | 2,256 | -3,937 |
Cash flows from financing activities: | ||||||||||||
Borrowings under revolving line of credit | ||||||||||||
0 | 8,000 | 17,000 | 55,000 | 37,000 | 55,000 | 117,500 | 15,000 | 10,000 | 15,500 | 0 | 0 | 0 |
Principal payments on revolving line of credit | ||||||||||||
8,000 | 34,000 | 18,000 | 77,000 | 35,000 | 58,000 | 79,500 | 15,000 | 10,000 | 13,500 | 0 | 0 | 0 |
Proceeds from issuance of term debt | ||||||||||||
403,500 | - | 0 | 50,000 | 0 | - | - | - | - | - | - | - | - |
Principal payments of long-term debt | ||||||||||||
48,750 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Payment of deferred purchase consideration | ||||||||||||
0 | 0 | 0 | 0 | 21,876 | 0 | 0 | 0 | 0 | - | - | - | - |
Finance Lease, Principal Payments | ||||||||||||
338 | - | - | - | 230 | - | - | - | - | - | - | - | - |
Principal payments of finance leases | ||||||||||||
- | - | - | - | - | - | - | - | - | 69 | 10 | 10 | 10 |
Payment of debt issuance costs | ||||||||||||
10,573 | 0 | 7 | 884 | 0 | - | - | - | - | 731 | 0 | 0 | 0 |
Proceeds from the exercise of stock options | ||||||||||||
5 | 2 | 43 | 39 | 151 | - | - | - | - | -784 | 718 | 39 | 644 |
Payment of tax withholding obligations related to net share settlements of restricted stock awards | ||||||||||||
792 | 111 | 2 | 112 | 968 | 1,194 | 114 | 346 | 370 | 5,619 | 498 | 910 | 496 |
Other | ||||||||||||
- | - | - | - | - | - | - | - | -130 | - | - | - | - |
Net cash provided by (used in) financing activities | ||||||||||||
335,052 | -26,592 | -1,789 | -1,973 | -20,923 | -4,380 | 37,776 | -1,123 | -500 | -3,951 | 210 | -881 | 138 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||||||||||||
-190 | 14 | -71 | 68 | 59 | 101 | -147 | -340 | 206 | 248 | 33 | 63 | 203 |
Net increase in cash, cash equivalents and restricted cash | ||||||||||||
65,425 | 4,246 | -10,789 | 7,248 | 244 | 7,710 | 2,573 | -25,178 | 1,516 | 5,793 | 18,674 | 675 | 8 |
Supplemental disclosure of cash flow information: | ||||||||||||
Interest paid | ||||||||||||
688 | 423 | 1,004 | 1,814 | 831 | 799 | 673 | 228 | 667 | 233 | 9 | 9 | 66 |
Income taxes paid | ||||||||||||
1,259 | 1,138 | 1,517 | 1,233 | 777 | 1,458 | 1,247 | 1,797 | 1,003 | 1,092 | 451 | 257 | 490 |
Income tax refunds received | ||||||||||||
0 | 1,466 | 67 | 124 | 100 | 111 | 206 | 24 | 196 | 183 | 11 | 0 | 80 |
Supplemental disclosure of non-cash investing activities: | ||||||||||||
Capital expenditures incurred, but not yet paid | ||||||||||||
6,300 | 2,006 | -1,056 | 1,217 | 399 | 783 | -753 | 729 | 368 | 742 | 79 | -96 | 318 |
Supplemental disclosure of non-cash financing activities: | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | ||||||||||||
3,182 | 657 | 687 | 1,744 | 4,334 | 2,850 | 303 | -94 | 5,253 | 14,290 | 1,392 | 1,981 | 2,852 |